Processing Your Payment

Please do not leave this page until complete. This can take a few moments.

August 29, 2017

Medtronic, Boston Scientific among investors in Calif. company

Boston Scientific's headquarters in Marlborough. The company was one of several to invest in a California company hoping to develop an inflammation treatment therapy.

Two Central Mass. manufacturers of medical devices have helped contribute $30 million to a California biomedical company looking to develop a bioelectronic therapy for chronic inflammatory diseases.

Medtronic, a Dublin-based medical device maker with an office in Littleton and Marlborough-based medical tech giant Boston Scientific were among several investors helping providing Series D funding for SetPoint Medical’s development.

SetPoint, based in Valencia, Calif., is developing a bioelectronic medicine platform using a small implanted device activating the body’s natural inflammatory reflex and produces anti-inflammatory effects previously only possible by drugs, according to a press release. 

The amount each company invested was not available Tuesday.

Sign up for Enews

WBJ Web Partners


Order a PDF